Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
CartiHeal logo — www.cartiheal.com

CartiHeal

www.cartiheal.com

Founded 2009 Israel Israel 19 employees Corporate Round Total: $41.50M Health Care, Manufacturing +1

General Information

Company Name CartiHeal
Founded Year 2009
Location Israel Israel
Employees 19
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with CartiHeal. To contact CartiHeal, visit cartiheal.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CartiHeal compare?

A PDF of CartiHeal and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CartiHeal soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CartiHeal

CartiHeal is an Israel-based medical device company that focuses on developing proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. The company's flagship product, Agili-C, is a cell-free, off-the-shelf implant that has received a CE mark for use in cartilage and osteochondral defects. The implant has undergone trials in leading centers in Europe and Israel, with over 400 patients benefiting from its application to treat a wide spectrum of cartilage lesions, from single focal lesions to multiple and large defects in patients suffering from osteoarthritis. In July 2020, CartiHeal secured a $15.00MCorporate Round investment from Bioventus. The company was founded in 2009 and operates in the Health Care and Manufacturing industries. Although the Agili-C implant is CE marked, it is important to note that in the United States, it is limited for use in an IDE study and is not available for commercial sale. With its innovative products and successful trials, CartiHeal is positioned to make a significant impact in the treatment of cartilage and osteochondral defects.

Business keywords: medical device, cartilage regeneration, cartilage repair, osteochondral defects, hyaline cartilage, regenerative medicine, CE marked implant, osteochondral implant, cell-free implant, minimally-invasive surgery, orthopedic surgery, traumatic joint injuries, osteoarthritis treatment, Israeli healthcare innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round $15.00M 1
Bioventus
Bioventus
16 Jul 2020
Corporate Round $2.50M 1
Bioventus
Bioventus
01 Feb 2018
Series D $3.00M 1
Elron Ventures
Elron Ventures
01 Feb 2015
Venture Round $5.00M 3
Accelmed Partners Elron Ventures Access Medical Ventures
Accelmed Partners, Elron Ventures +1
29 Oct 2013
Venture Round $10.00M 3
Accelmed Partners Elron Ventures Access Medical Ventures
Accelmed Partners, Elron Ventures +1
09 Jul 2012
Series D $5.00M 3
Accelmed Partners Elron Ventures Access Medical Ventures
Accelmed Partners, Elron Ventures +1
01 Feb 2012
Series C $300.00K 5
aMoon Elron Ventures Peregrine Ventures
aMoon, Elron Ventures +3
07 Apr 2011
Series A $695.00K 5
Accelmed Partners Elron Ventures Peregrine Ventures
Accelmed Partners, Elron Ventures +3
11 Apr 2009

CartiHeal Alternatives & Competitors

View All Alternatives
CartiHeal vs
osteobionix
osteobionix Spain

From replacement to regeneration

11 employees
Biotechnology, Health Care
CartiHeal vs
Miach Orthopaedics, Inc.
Miach Orthopaedics, Inc. United States

BEAR Implant: The Bridge to ACL Restoration

Series B
73 employees
Biotechnology, Health Care
CartiHeal vs
ORTEQ Sports Medicine
ORTEQ Sports Medicine United Kingdom

We aim to reduce patient suffering from meniscus and articular cartilage injury or degeneration by c...

Venture round
9 employees
Biotechnology, Health Care
View all alternatives

FAQ About CartiHeal

www.cartiheal.com
CartiHeal was founded in 2009.
CartiHeal is headquartered in Israel.
CartiHeal operates in Health Care, Manufacturing and Medical Devices. Its work centres on medical device, cartilage regeneration, cartilage repair and osteochondral defects.
CartiHeal has approximately 19 employees.
CartiHeal has completed 8 funding rounds, raising a total of $41.50M. The latest funding stage is Corporate Round.
Top alternatives and competitors to CartiHeal include osteobionix, Miach Orthopaedics, Inc., ORTEQ Sports Medicine, meidrix biomedicals GmbH, CoNextions Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CartiHeal and osteobionix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CartiHeal, https://bouncewatch.com/company/cartiheal, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout